Multiple myeloma associated with porphyria cutanea tarda: a possible role of bortezomib?
Cabanillas
Miguel
M
Peteiro
Carmen
C
Toribio
Jaime
J
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000175:diagnosis; D011719:Pyrazines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib